Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy
of administered PTH 1–34
J. Clin. Invest. Dengshun Miao, et al. 115:2402 doi:10.1172/JCI24918 [
Go to this article.]
Figure 7Data from quantitative assessment. (
A) BV/TV. (
B) Trabecular number. (
C) Trabecular thickness. (
D) Trabecular separation. (
E) Trabecular connectivity (CD). (
F) Degree of anisotropy. (
G) Structure model index. (
H) Cortical thickness (Ct.Th). Data shown represent mean ± SEM of 5–7 animals per group. White bars,
Pthrp+/+ mice; black bars,
Pthrp+/– mice.
